Biota Pharmaceuticals sells antibiotic assets to Spero Therapeutics
Financial terms of the transaction were not disclosed. "This transaction gives us the opportunity to economically benefit from the antibiotic assets in our infectious disease portfolio and to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.